In addition, it is known that SphK1 conformation and activities can be influenced by several conditions including pH,64 guanidinium chloride65 and urea,66 new SphK1 inhibitors have been developed for breast cancer treatment,67 which could be applied for NEPC therapy in the future. The gene discussed is SPHK1; the disease is breast carcinoma.